Author

S. K. Jung

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

P. Kurre· 2 shared A. Conte· 1 shared A. Olia· 1 shared D. M. Taylor· 1 shared D. V. Mitchell· 1 shared D.-W. Chen· 1 shared E. B. Perez· 1 shared F. Muecksch· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

P. Kurre

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Dynamic Tracking of Native Precursors in Adult Mice

S. Liu, S. E. Adams, H. Zheng, J. Ehnot, S. K. Jung, G. Jeffrey, T. Menna, L. Purton, H. Lee, P. Kurre

The paper develops a method to quantify hematopoietic precursors in mice, showing their contribution to both normal and perturbed hematopoiesis, and applies it to a Fanconi Anemia model.

bioRxiv · Apr 2, 2024Cell Biology

Inflammatory Recruitment of Healthy Hematopoietic Stem and Progenitor Cells in the Acute Myeloid Leukemia Niche

D.-W. Chen, J.-M. Fan, J. M. Schrey, D. V. Mitchell, S. K. Jung, S. N. Hurwitz, E. B. Perez, M. Muraro, M. Carroll, D. M. Taylor, P. Kurre

This study shows that healthy hematopoietic stem and progenitor cells (HSPCs) adopt inflammatory gene expression programs in the AML niche, driven by AML-derived extracellular vesicles.

bioRxiv · Nov 22, 2023Cancer Biology

Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants

J. Xu, K. Xu, S. K. Jung, A. Conte, J. Lieberman, F. Muecksch, J. C. C. Lorenzi, S. Park, Z. Wang, L. Tessarollo, T. Bylund, G.-Y. Chuang, A. Olia, I.-T. Teng, T. Zhou, , R. Casellas

This paper isolates and characterizes nanobodies from camelids and engineered mice that neutralize SARS-CoV-2 variants through conserved epitopes and multimeric avidity.

bioRxiv · Mar 4, 2021 · PreprintImmunology